These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 9612600

  • 1. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
    Abrams RA, Pajak TF, Haulk TL, Flam M, Asbell SO.
    Cancer J Sci Am; 1998; 4(3):178-84. PubMed ID: 9612600
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
    Jang JW, Park YM, Bae SH, Choi JY, Yoon SK, Chang UI, Nam SW, Kim BS.
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
    [Abstract] [Full Text] [Related]

  • 3. Hepatic arterial infusion chemotherapy with use of an implanted port system in patients with advanced hepatocellular carcinoma: prognostic factors.
    Hamada A, Yamakado K, Nakatsuka A, Takaki H, Akeboshi M, Takeda K.
    J Vasc Interv Radiol; 2004 Aug; 15(8):835-41. PubMed ID: 15297587
    [Abstract] [Full Text] [Related]

  • 4. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
    Hung A, Crane C, Delclos M, Ballo M, Ajani J, Lin E, Feig B, Skibber J, Janjan N.
    Cancer; 2003 Mar 01; 97(5):1195-202. PubMed ID: 12599225
    [Abstract] [Full Text] [Related]

  • 5. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Yamasaki T, Kimura T, Kurokawa F, Aoyama K, Ishikawa T, Tajima K, Yokoyama Y, Takami T, Omori K, Kawaguchi K, Tsuchiya M, Terai S, Sakaida I, Okita K.
    J Gastroenterol; 2005 Jan 01; 40(1):70-8. PubMed ID: 15692792
    [Abstract] [Full Text] [Related]

  • 6. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B, Yu J, Wang L, Li C, Zhou T, Zhai L, Xing L.
    Am J Clin Oncol; 2003 Aug 01; 26(4):e92-9. PubMed ID: 12902905
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R, López-Pousa A, Martínez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Martí JL, Lobo F, Pastor P, Valentí V, Belón J, Sánchez MA, Chaib C, Pallarés C, Antón A, Cervantes A, Paz-Ares L, Cortés-Funes H.
    J Clin Oncol; 2005 Dec 01; 23(34):8636-45. PubMed ID: 16275937
    [Abstract] [Full Text] [Related]

  • 10. Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
    Witte RS, Cnaan A, Mansour EG, Barylak E, Harris JE, Schutt AJ.
    Cancer; 2001 Mar 01; 91(5):1020-8. PubMed ID: 11251955
    [Abstract] [Full Text] [Related]

  • 11. Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma.
    Lee J, Park JO, Kim WS, Park SH, Park KW, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Joh J, Kim K, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Park K.
    Cancer Chemother Pharmacol; 2004 Nov 01; 54(5):385-90. PubMed ID: 15248028
    [Abstract] [Full Text] [Related]

  • 12. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
    Hong RL, Sheen TS, Ko JY, Hsu MM, Wang CC, Ting LL.
    Br J Cancer; 1999 Aug 01; 80(12):1962-7. PubMed ID: 10471046
    [Abstract] [Full Text] [Related]

  • 13. Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases.
    Yang TS, Chang HK, Chen JS, Lin YC, Liau CT, Chang WC.
    J Gastroenterol; 2004 Aug 01; 39(4):362-9. PubMed ID: 15168248
    [Abstract] [Full Text] [Related]

  • 14. Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advanced stage endometrial carcinoma: a Gynecologic Oncology Group trial.
    Soper JT, Reisinger SA, Ashbury R, Jones E, Clarke-Pearson DL.
    Gynecol Oncol; 2004 Oct 01; 95(1):95-100. PubMed ID: 15385116
    [Abstract] [Full Text] [Related]

  • 15. Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.
    Order SE, Stillwagon GB, Klein JL, Leichner PK, Siegelman SS, Fishman EK, Ettinger DS, Haulk T, Kopher K, Finney K.
    J Clin Oncol; 1985 Dec 01; 3(12):1573-82. PubMed ID: 2415692
    [Abstract] [Full Text] [Related]

  • 16. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
    Leung WT, Lau WY, Ho S, Chan M, Leung N, Lin J, Ho KC, Metreweli C, Johnson PJ, Li AK.
    J Nucl Med; 1994 Aug 01; 35(8):1313-8. PubMed ID: 7519259
    [Abstract] [Full Text] [Related]

  • 17. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.
    Ishida K, Hirooka M, Hiraoka A, Kumagi T, Uehara T, Hiasa Y, Horiike N, Onji M.
    Jpn J Clin Oncol; 2008 Sep 01; 38(9):596-603. PubMed ID: 18772170
    [Abstract] [Full Text] [Related]

  • 18. Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trial.
    Leichman CG, Jacobson JR, Modiano M, Daniels JR, Zalupski MM, Doroshow JH, Fletcher WS, Macdonald JS.
    Cancer; 1999 Sep 01; 86(5):775-81. PubMed ID: 10463975
    [Abstract] [Full Text] [Related]

  • 19. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhou ZH, Liu LM, Cheng WW, Meng ZQ, Lin JH, Chen Z, Zhang XJ, Jiang GL.
    Zhonghua Zhong Liu Za Zhi; 2006 Mar 01; 28(3):222-6. PubMed ID: 16875612
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA, Cooper DL.
    J Clin Oncol; 2004 Aug 01; 22(15):3061-9. PubMed ID: 15284256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.